Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a mapping study

Ines Rombach, Marvi Iftikhar, Gurleen S. Jhuti, Anders Gustavsson, Pascal Lecomte, Mark Belger, Ron Handels, Amparo Y. Castro Sanchez, Jan Kors, Louise Hopper, Marcel Olde Rikkert, Geir Selbæk, Astrid Stephan, Sietske A.M. Sikkes, Bob Woods, Manuel Gonçalves-Pereira, Orazio Zanetti, Inez H.G.B. Ramakers, Frans R.J. Verhey, John GallacherFilipa Landeiro, Alastair M. Gray

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: The Quality of Life Alzheimer’s Disease Scale (QoL-AD) is commonly used to assess disease specific health-related quality of life (HRQoL) as rated by patients and their carers. For cost-effectiveness analyses, utilities based on the EQ-5D are often required. We report a new mapping algorithm to obtain EQ-5D indices when only QoL-AD data are available. Methods: Different statistical models to estimate utility directly, or responses to individual EQ-5D questions (response mapping) from QoL-AD, were trialled for patient-rated and proxy-rated questionnaires. Model performance was assessed by root mean square error and mean absolute error. Results: The response model using multinomial regression including age and sex, performed best in both the estimation dataset and an independent dataset. Conclusions: The recommended mapping algorithm allows researchers for the first time to estimate EQ-5D values from QoL-AD data, enabling cost-utility analyses using datasets where the QoL-AD but no utility measures were collected.

Original languageEnglish
Pages (from-to)867-879
JournalQUALITY OF LIFE RESEARCH
Volume30
Issue number3
Early online date17 Oct 2020
DOIs
Publication statusPublished - Mar 2021

Keywords

  • Cross-walking
  • Dementia
  • Health related quality of life
  • Mapping algorithm
  • Preference based measures

Fingerprint

Dive into the research topics of 'Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a mapping study'. Together they form a unique fingerprint.

Cite this